Anti-α-inhibin: Marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration

Cancer

Volumn 87, Issue 3, 1999, Pages 168-172

  Fetsch, Patricia A ^a   Powers, Celeste N ^b   Zakowski, Maureen F ^c   Abati, Andrea ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

inhibin; Adrenocortical carcinoma; Fine needle aspiration; Immunocytochemistry; Renal cell carcinoma

Indexed keywords

ALPHA INHIBIN ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG;

ADRENAL CORTEX CARCINOMA; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CLINICAL ARTICLE; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; PRIORITY JOURNAL;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ANTIBODIES, NEOPLASM; BIOPSY, NEEDLE; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBINS; KIDNEY; KIDNEY NEOPLASMS; PEPTIDES; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0033603639     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990625)87:3<168::AID-CNCR11>3.0.CO;2-V     Document Type: Article

References (24)

1. McCluggage W, Maxwell P, Sloan J. Immunohistochemical staining of ovarian granulosa cell tumors with monoclonal antibody against inhibin. Hum Pathol 1997;28(9):1034-8.
2. Pelkey T, Frierson H, Mills S, Stoler M. The diagnostic utility of inhibin staining in ovarian neoplasms. Int J Gynecol Pathol 1998;17(2):97-105.
3. Pelkey T, Frierson H, Mills S, Stoler M. The a subunit of inhibin in adrenal cortical neoplasia. Mod Pathol 1998;11(6): 516-23.
4. Flemming P, Wellmann A, Maschek H, Lang H, Georgii A. Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. Am J Surg Pathol 1995;19(8):927-33.
5. Chen CLC. Inhibin and activin as paracrine/autocrine factors. Endocrinology 1993;132:4-5.
6. Jaatinen T, Penttila T, Kaipia A, Ekfors T, Parvinen M, Toppari J. Expression of inhibin alpha, betaA, and betaB messenger ribonucleic acids in the normal human ovary and in polycystic ovarian syndrome. J Endocrinol 1994;143:127-37.
7. Lappohn R, Burger H, Bouma J, Bangah M, Krans M, Brujin H. Inhibin as a marker for granulosa-cell tumors. N Engl J Med 1989;321:790-3.
8. Spencer S, Rabinovici J, Mesiano S, Goldsmith P, Jaffe R. Activin and inhibin in the human adrenal gland. Regulation and differential effects in fetal and adult cells. J Clin Invest 1992;90:142-9.
9. McCluggage W, Shanks J, Whiteside C, Maxwell P, Banerjee S, Biggart J. Immunohistochemical study of testicular sex cord-stromal tumors, including staining with anti-inhibin antibody. Am J Surg Pathol 1998;22(5):615-9.
10. Chivite A, Matias-Guiu X, Pons C, Algaba F, Prat J. Inhibin A expression in adrenal neoplasms. Appl Immunohistochem 1998;6(1):42-9.
11. Kommoss F, Oliva E, Bhan A, Young R, Scully R. Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study. Mod Pathol 1998;11(7):656-64.
12. Costa M, Ames P, Walls J, Roth L. Inhibin immunohistochemistry applied to ovarian neoplasms: a novel, effective, diagnostic tool. Hum Pathol 1997;28(11):1247-54.
13. Hildebrandt R, Rouse R, Longacre T. Value of inhibin in the identification of granulosa cell tumors of the ovary. Hum Pathol 1997;28(12):1387-95.
14. Sharma S, Singh R, Verma K. Cytomorphology of adrenocortical carcinoma and comparison with renal cell carcinoma. Acta Cytol 1997;41(2):385-92.
15. Sasano H, Shizawa S, Nagura H. Adrenocortical cytopathology. Am J Clin Pathol 1995;104(2):161-6.
16. Gaffey M, Traweek S, Mills S, Travis W, Lack E, Medeiros L, et al. Cytokeratin expression in adrenocortical neoplasia: an immunohistochemical and biochemical study with implications for the differential diagnosis of adrenocortical, hepatocellular, and renal cell carcinoma. Hum Pathol 1992;23: 144-53.
17. Wick M, Cherwitz D, McGlennen R, Dehner L. Adrenocortical carcinoma. Am J Pathol 1986;122(2):343-52.
18. Fetsch P, Cormier J, Hijazi Y. Immunocytochemical detection of MART-1 in fresh and paraffin embedded malignant melanomas. J Immunother 1997;20(1):60-4.
19. Rodriguez-Soto J, Warnke R, Rouse R. Endogenous avidin-binding activity in paraffin-embedded tissue revealed after microwave treatment. Appl Immunohistochem 1997;5(1): 59-62.
20. Mackay B, Ordonez N, Khoursand J. The ultrastructure and immunocytochemistry of renal cell carcinoma. Ultrastruct Pathol 1987;11:483-502.
21. Miettinen M. Neuroendocrine differentiation in adrenocortical carcinoma: new immunohistochemical findings supported by electron microscopy. Lab Invest 1992;66(2):169-74.
22. Tartour E, Caillou B, Tenenbaum F, Schroder S, Luciani S, Talbot M, et al. Immunohistochemical study of adrenocortical carcinoma: predictive value of the D11 monoclonal antibody. Cancer 1993;72(11):3296-303.
23. DeLong W, Grignon D, Eberwein P, Shum D, Wyatt J. Sarcomatoid renal cell carcinoma. Arch Pathol Lab Med 1993; 117:636-40.
24. McCluggage W, Burton J, Maxwell P, Sloan J. Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against α-inhibin. J Clin Pathol 1998;51:114-6.